Is Titan Pharmaceuticals, Inc. common stock (TTNP) Stock a Attractive Value?

Thursday, December 23, 2021 10:17 AM | InvestorsObserver Analysts

Mentioned in this article

Is Titan Pharmaceuticals, Inc. common stock (TTNP) Stock a Attractive Value?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is down -64.53% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 29 out of a possible 100. That rank is influenced by a short-term technical score of 4. TTNP's rank also includes a long-term technical score of 7. The fundamental score for TTNP is 76. In addition to the average rating from Wall Street analysts, TTNP stock has a mean target price of $7.00. This means analysts expect the stock to rise 503.45% over the next 12 months.

TTNP has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What's Happening with TTNP Stock Today

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has fallen -7.2% while the S&P 500 is up 0.64% as of 10:16 AM on Thursday, Dec 23. TTNP is down -$0.09 from the previous closing price of $1.25 on volume of 206,430 shares. Over the past year the S&P 500 is up 28.08% while TTNP is down -64.53%. TTNP lost -$0.48 per share in the over the last 12 months. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.